About Algorithmic Biologics
Algorithmic Biologics is a company based in Bengaluru (India) founded in 2021 by Manoj Gopalkrishnan. Algorithmic Biologics has raised $2.84 million across 3 funding rounds from investors including Bharat Fund and Axilor Ventures. The company has 1 employees. Algorithmic Biologics operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
- Headquarter Bengaluru, India
- Employees 1
- Founders Manoj Gopalkrishnan
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website algorithmicbiologics.com
- Social LinkedIn X
- Legal Name Algorithmic Biologics Private Limited
- Date of Incorporation 03 Mar, 2021
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.63 Cr
FY 2025 · +322% YoY
- Net Loss-₹23.7 Lakh
FY 2025 · -15% margin
- EBITDA-₹20.5 Lakh
FY 2025 · -13% margin
- Total Equity Funding$2.84M (USD)
in 3 rounds
- Latest Funding Round$2.5M (USD), Seed
Nov 2023
- InvestorsBharat Fund
& 1 more
- Employee Count1
Associated legal entities of Algorithmic Biologics
Algorithmic Biologics operates through Algorithmic Biologics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Algorithmic Biologics Private Limited CIN U73100KA2021PTC144837 | Active | 03 Mar 2021 | Bangalore, Karnataka | ₹1.6 Cr | – | 3 | View details |
Funding Insights of Algorithmic Biologics
Algorithmic Biologics has successfully raised a total of $2.84M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.84M
- Total Rounds 3
- Last Round Seed — $2.5M
- First Round $341,975
(Jul 2021)
- Investors Count 2
All 3 funding rounds of Algorithmic Biologics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $2.5M | Seed | $10.93M | Bharat Innovation Fund | |
| Jan 2022 | – | Seed | – | – | |
| Jul 2021 | $341,975 | Seed | $2.08M | Axilor Ventures | – |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2023 | $10.93M | •••••••• |
| Jul 2021 | $2.08M | •••••••• |
Last known valuation $10.93M (Nov 2023). 2 investors in total: 2 institutional.
Investors in Algorithmic Biologics
Algorithmic Biologics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bharat Fund and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Funding for IP-driven deep-tech and digitization-led inclusive solutions. | 2017 | bharat.fund | Ahmedabad, India | |
Venture capital firm investing in early-stage startups in technology sectors. | 2014 | axilor.com | Bengaluru, India |
Investor details for Algorithmic Biologics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Algorithmic Biologics Private Limited (Algorithmic Biologics)
Algorithmic Biologics Private Limited is the primary company behind Algorithmic Biologics. The board of Algorithmic Biologics Private Limited currently have 3 directors; the longest-serving is Manoj Gopalkrishnan, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manoj Gopalkrishnan DIN 09089867 | Director | 03 Mar 2021 | 5 yrs 7 mo | Algorithmic Biologics Private Limited |
| Bhanu Priya Vaddiparthi DIN 08173206 | Director | 03 Mar 2021 | 5 yrs 7 mo | Algorithmic Biologics Private Limited |
| Nidhi Mathur DIN 01848845 | Nominee Director | 30 Jan 2024 | 2 yrs 8 mo | Algorithmic Biologics Private Limited |
People of Algorithmic Biologics
1 people are tracked at Algorithmic Biologics (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Algorithmic Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Algorithmic Biologics
Figures of Algorithmic Biologics Private Limited, the primary company behind Algorithmic Biologics, for FY 2025. Revenue was ₹1.63 Cr (+322% year on year). Net loss was -₹23.7 Lakh (-15% margin). EBITDA was -₹20.5 Lakh (-13% margin). Revenue has grown at a compounded annual rate of +61% over three years.
- ₹1.63 CrRevenue · FY 2025 · +322% YoY
- -₹23.7 LakhNet loss · -15% margin
- -₹20.5 LakhEBITDA · -13% margin
- ₹5.3 LakhPaid-up capital
- +61%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Algorithmic Biologics Private Limited are on its company page.
Detailed financial statements for Algorithmic Biologics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Algorithmic Biologics
4 dated milestones of Algorithmic Biologics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Algorithmic Biologics is founded.
- Funding First funding round of $342K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $2.5M.
Competitors of Algorithmic Biologics
Algorithmic Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| cellarity.com | 2015 | Cambridge, United States | $294M | 117 | Developer of drugs to treat various diseases | |
| metaphorebio.com | 2021 | Cambridge, United States | $50M | – | Provider of machine language and computational platform for drug discovery | |
| panakeia.ai | 2018 | London, United Kingdom | $3.79M | 12 | AI-based software is provided for cancer diagnosis and precision treatment. | |
| evolvedbynature.com | 2013 | Medford, United States | $190M | 99 | Digital technology for biomedicinal molecule development in research is utilized. | |
| lizard.bio | 2018 | Ghent, Belgium | – | 22 | Software solutions for bioinformatics data processing and integration are provided. | |
| stonewise.cn | 2018 | Haidian, China | $100M | – | Molecular modeling software is provided using AI for molecule design. | |
| etisense.com | 2017 | Lyon, France | $507,979 | – | Wearable cardio-respiratory monitoring devices are developed using inductive plethysmography. |
Detailed competitors of Algorithmic Biologics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Algorithmic Biologics
Complete news archive for Algorithmic Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Algorithmic Biologics
10 companies that operate in the same segment as Algorithmic Biologics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Algorithmic Biologics
Algorithmic Biologics was founded in 2021.
Algorithmic Biologics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Manoj Gopalkrishnan is the current CEO of Algorithmic Biologics. They have also founded this company.
Algorithmic Biologics is a funded company, having raised a total of $2.84M across 3 funding rounds to date. The company's 1st funding round was a Seed of $341.98K, raised on Jul 2021.
Algorithmic Biologics has 1 employees.
The primary company behind Algorithmic Biologics, Algorithmic Biologics Private Limited, reported revenue of ₹1.63 Cr for FY 2025, up 322% year on year.
Provider of software solutions for molecular diagnostics and discovery. The company offers Tapestry that integrates with standard molecular testing workflows, enabling the execution of computing applications that enhance molecular testing.
Algorithmic Biologics has 2 investors. Key investors include Bharat Fund, and Axilor Ventures.
The valuation of Algorithmic Biologics is $10.93M as of Nov 2023.
Algorithmic Biologics operates through Algorithmic Biologics Private Limited.
The legal entities of Algorithmic Biologics currently have 3 directors, including Manoj Gopalkrishnan, Bhanu Priya Vaddiparthi, Nidhi Mathur.